Carvedilol
Back to searchMolecule Structure
Scientific Name
Carvedilol
Description of the Drug
Carvedilol is a non selective beta-adrenergic antagonist used to treat mild to severe chronic heart failure, hypertension, and left ventricular dysfunction following myocardial infarction in clinically stable patients.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01136
http://www.drugbank.ca/drugs/DB01136
Brand Name(s)
Carvedilol, Coreg, Coreg CR, Eucardic 12.5, Eucardic 25, Eucardic 3.125, Eucardic 6.25
Company Owner(s)
Sun Pharmaceutical Industries Inc, Mylan Pharmaceuticals Inc, Impax Laboratories Inc, Zydus Pharmaceuticals Usa Inc, Chartwell Molecular Holdings Llc, Woodward Pharma Services Llc, Teva Pharmaceuticals Usa Inc, Rubicon Research Private Ltd, Caraco Pharmaceutical Laboratories Ltd, Aurobindo Pharma Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Adrenergic receptor beta | PROTEIN FAMILY | ANTAGONIST | CHEMBL2094118 |
| Adrenergic receptor alpha-1 | PROTEIN FAMILY | ANTAGONIST | CHEMBL2094251 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL22293 | ||
| PharmGKB | PA448817 | ||
| Human Metabolome Database | HMDB0015267 | ||
| DrugBank | DB01136 | ||
| PubChem: Thomson Pharma | 14855122 | ||
| PubChem | 2585 | ||
| Mcule | MCULE-7944987271 | ||
| LINCS | LSM-1310 | ||
| Nikkaji | J33.955E | ||
| BindingDB | 25759 | ||
| EPA CompTox Dashboard | DTXSID8022747 | ||
| DrugCentral | 522 | ||
| Brenda | 24148 | ||
| ChemicalBook | CB8351959 | ||
| Guide to Pharmacology | 551 | ||
| rxnorm | CARVEDILOL PHOSPHATE | CARVEDILOL | COREG |
| PubChem: Drugs of the Future | 12013067 | ||
| KEGG Ligand | C06875 | ||
| ChEBI | 3441 |
